Lab Manager | Run Your Lab Like a Business
German and Ukrainian flags on a desk over defocused background

BioMed X Institute Launches Ukraine Refugee Funding Program

The program addresses doctoral students and master-level scientists in the field of life sciences

by
BioMed X Institute

BioMed X is an independent research institute located at the campus environment of the University of Heidelberg in Germany. We operate at the interface between academia and industry and perform...

ViewFull Profile.
Learn about ourEditorial Policies.
Register for free to listen to this article
Listen with Speechify
0:00
5:00

HEIDELBERG, GERMANY — German independent research institute BioMed X announced the start of its “Ukraine Refugee Funding Program” that supports doctoral students and master-level researchers in the life sciences who cannot continue their work at institutions in Ukraine. In collaboration with some of its partners, BioMed X aims to give these scientists the opportunity to continue their work in a research group at the BioMed X Institute in Heidelberg, Germany, for a period of up to four years.

Thomas Rückle, senior vice president and head of research at the BioMed X Institute: “The situation in Ukraine is a tragedy, which requires a joint effort to offer support and help. Our BioMed X Institute is a place where early-career scientists are given the opportunity to develop themselves. Together with some of our partners we launched this funding program because we sincerely hope to provide a scientific home for some of the researchers who cannot continue their career in Ukraine.”

Get training in Metrics and Productivity and earn CEUs.One of over 25 IACET-accredited courses in the Academy.
Metrics and Productivity Course

Ideal candidates have a master’s degree, as well as research experience, in either molecular/cell biology, bio-organic chemistry, pharmacology, or physics. German language knowledge is not required. Both Ukrainian and non-Ukrainian citizens are welcome to apply, provided that they fulfill the eligibility criteria.

- This press release was originally published on the BioMed X Institute website